NCT05768932
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05768932
Title BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors SillaJen, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Yale New Haven Hospital NOT_YET_RECRUITING New Haven Connecticut 06510 United States Details
University of Miami Health System RECRUITING Coral Gables Florida 33146 United States Details
Montefiore Medical Center RECRUITING The Bronx New York 10461 United States Details
OHSU Knight Cancer Institute RECRUITING Portland Oregon 97239 United States Details
Mary Crowley Cancer Research WITHDRAWN Dallas Texas 75230 United States Details
The University of Texas MD Anderson Cancer Center NOT_YET_RECRUITING Houston Texas 77030 United States Details
The Catholic University of Korea, Seoul St. Mary's Hospital RECRUITING Seoul 06591 South Korea Details
Asan Medical Center RECRUITING Seoul South Korea Details
Korean University Anam Hospital RECRUITING Seoul South Korea Details
Samsung Medical Center RECRUITING Seoul South Korea Details
Seoul National University Hospital RECRUITING Seoul South Korea Details
Severance Hospital, Yonsei University Health System RECRUITING Seoul South Korea Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field